Adil Daud

Also affiliated with UCSF Helen Diller Family Comprehensive Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 21 papers. Top paper: “Discovering dominant tumor immune archetypes in a pan-cancer census”.

Discovering dominant tumor immune archetypes in a pan-cancer census

Cell(2021)10.1016/j.cell.2021.12.004

N/A

4.2DataRank · unranked

176 citations

Bushra Samad, Jessica Tsui, Nayvin W. Chew, Peter Yan, Gabriella C. Reeder +75 more

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002478

N/A

4.0DataRank · unranked

140 citations

Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl +24 more

Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma

European Journal of Cancer(2020)10.1016/j.ejca.2020.11.010

N/A

3.9DataRank · unranked

100 citations

Wen-Jen Hwu, Omid Hamid, Antoni Ribas, Jeffrey S. Weber, Adil Daud +18 more

TCR-sequencing in cancer and autoimmunity: barcodes and beyond

Trends in Immunology(2022)10.1016/j.it.2022.01.002

N/A

1.4DataRank · unranked

54 citations

Kaitlyn A. Lagattuta, Benjamin Y. Lu, Liliana E. Lucca, Adil Daud, David A. Hafler +4 more

Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis

Science Immunology(2020)10.1126/sciimmunol.aba0759

N/A

0.858DataRank · unranked

304 citations

Sadaf Mehdizadeh, Jennifer Smith, Arabella Young, Ilgiz A. Mufazalov, Cody T. Mowery +3 more

An analysis of genetic heterogeneity in untreated cancers

Nature Reviews Cancer(2019)10.1038/s41568-019-0185-x

N/A

0.805DataRank · unranked

213 citations

Marina Baretti, Jeffrey M. Gerold, Alvin P. Makohon-Moore, Adil Daud, Christine A. Iacobuzio–Donahue +5 more

The State of Melanoma: Emergent Challenges and Opportunities

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4092

N/A

0.705DataRank · unranked

109 citations

Clara Curiel‐Lewandrowski, David E. Fisher, Susan M. Swetter, Hensin Tsao, Julio A. Aguirre‐Ghiso +31 more

Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.30.294959

N/A

0DataRank · unranked

4 citations

Osmaan Shahid, Kaitlyn A. Lagattuta, Kelly M. Mahuron, Jacob M. Luber, Margaret M. Lowe +16 more

Layilin Anchors Regulatory T Cells in Skin

The Journal of Immunology(2021)10.4049/jimmunol.2000970

N/A

0DataRank · unranked

25 citations

Victoire Gouirand, Devi P Boda, Jingxian Zhang, Sofia V. Gearty, Bahar Zirak +18 more

A Pan-Cancer Census of Dominant Tumor Immune Archetypes

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.26.441344

N/A

0DataRank · unranked

4 citations

Bushra Samad, Jessica Tsui, Nayvin W. Chew, Peter Yan, Gabriella C. Reeder +32 more

Layilin augments integrin activation to promote antitumor immunity

The Journal of Experimental Medicine(2020)10.1084/jem.20192080

N/A

0DataRank · unranked

69 citations

J. Moreau, Jeff E. Glasgow, Devi P Boda, Mariela Pauli, Victoire Gouirand +16 more

The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma

Research Square(2023)10.21203/rs.3.rs-1297358/v3

N/A

0DataRank · unranked

1 citations

Li-Nan Chen, Yixuan James Zheng, Wilson Ho, Martina Sanlorenzo, Igor Vujic +21 more

Data from Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial

(2023)10.1158/1078-0432.c.6517464

N/A

0DataRank · unranked

0 citations

Jana L. Dawson, Ronald C. DeConti, Elona Biçaku, Douglas C. Marchion, Sem Bastien +6 more

Data from Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma

(2023)10.1158/1078-0432.c.6528642

N/A

0DataRank · unranked

0 citations

Natalie V. Longino, Natalie J. Miller, Rima M. Kulikauskas, Jayasri G. Iyer, Dafina Ibrani +12 more

Data from Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial

(2023)10.1158/1078-0432.c.6517464.v1

N/A

0DataRank · unranked

0 citations

Jana L. Dawson, Ronald C. DeConti, Elona Biçaku, Douglas C. Marchion, Sem Bastien +6 more

The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cell survival in NRAS/MAPK-driven melanoma

Research Square(2023)10.21203/rs.3.rs-1297358/v2

N/A

0DataRank · unranked

0 citations

Li-Nan Chen, Yixuan James Zheng, Wilson Ho, Martina Sanlorenzo, Igor Vujic +21 more

Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response

BJC Reports(2024)10.1038/s44276-024-00057-7

N/A

0DataRank · unranked

19 citations

Saya Jacob, Muhammad Zaki Hidayatullah Fadlullah, Chaorong Wu, Clinton Wu, Laura A. Huppert +16 more

The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma

Molecular Cancer(2024)10.1186/s12943-024-01955-7

N/A

0DataRank · unranked

15 citations

Li-Nan Chen, Yixuan James Zheng, Wilson Ho, Martina Sanlorenzo, Igor Vujic +21 more

Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma

Cancer Research(2025)10.1158/0008-5472.can-23-3918

N/A

0DataRank · unranked

11 citations

Osmaan Shahid, Prachi Sao, Clinton Wu, Alexandra M. Haugh, Laura A. Huppert +13 more

Association of prior immune checkpoint blockade (ICB) with longer progression-free survival (PFS) in patients treated with intermittent versus continuous dabrafenib and trametinib: A post-hoc analysis of S1320.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10039

N/A

0DataRank · unranked

1 citations

Megan Othus, Adil Daud, Janice M. Mehnert, Thach‐Giao Truong, Robert M. Conry +15 more

Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment

The Journal of Experimental Medicine(2020)10.1084/jem.20200920

N/A

0DataRank · unranked

127 citations

Osmaan Shahid, Kaitlyn A. Lagattuta, Kelly M. Mahuron, Jacob M. Luber, Margaret M. Lowe +16 more